BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31563411)

  • 1. Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model.
    Niyazi M; Niemierko A; Paganetti H; Söhn M; Schapira E; Goldberg S; Adams J; Kim V; Oh KS; Hwang WL; Lu HM; Belka C; Busse PM; Loeffler JS; Shih HA
    Radiother Oncol; 2020 Jan; 142():154-161. PubMed ID: 31563411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy.
    Stokkevåg CH; Indelicato DJ; Herfarth K; Magelssen H; Evensen ME; Ugland M; Nordberg T; Nystad TA; Hægeland C; Alsaker MD; Ulven K; Dale JE; Engeseth GM; Boer CG; Toussaint L; Kornerup JS; Pettersen HES; Brydøy M; Brandal P; Muren LP
    Acta Oncol; 2019 Oct; 58(10):1416-1422. PubMed ID: 31364899
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.
    McDonald MW; Liu Y; Moore MG; Johnstone PA
    Radiat Oncol; 2016 Feb; 11():32. PubMed ID: 26922239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.
    Chaikh A; Calugaru V; Bondiau PY; Thariat J; Balosso J
    Int J Radiat Biol; 2018 Sep; 94(9):789-797. PubMed ID: 29878849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of RBE variations on risk estimates of temporal lobe necrosis in patients treated with intensity-modulated proton therapy for head and neck cancer.
    Engeseth GM; Hysing LB; Yepes P; Pettersen HES; Mohan R; Fuller CD; Stokkevåg CH; Wu R; Zhang X; Frank SJ; Gunn GB
    Acta Oncol; 2022 Feb; 61(2):215-222. PubMed ID: 34534047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
    Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
    Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation Necrosis and White Matter Lesions in Pediatric Patients With Brain Tumors Treated With Pencil Beam Scanning Proton Therapy.
    Bojaxhiu B; Ahlhelm F; Walser M; Placidi L; Kliebsch U; Mikroutsikos L; Morach P; Bolsi A; Lomax T; Pica A; Weber DC
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):987-996. PubMed ID: 29485079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy.
    Pedersen J; Flampouri S; Bryant C; Liang X; Mendenhall N; Li Z; Liu M; Muren LP
    Radiother Oncol; 2020 Jan; 142():253-260. PubMed ID: 31630864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model-based calculation of thyroid gland normal tissue complication probability in head and neck cancer patients after radiation therapy.
    Kinclová I; Hajtmanová E; Matula P; Balentová S; Muríň P; Ďuroška M; Kozlíková K
    Strahlenther Onkol; 2020 Jun; 196(6):561-568. PubMed ID: 32016495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of spot size on plan quality of spot scanning proton radiosurgery for peripheral brain lesions.
    Wang D; Dirksen B; Hyer DE; Buatti JM; Sheybani A; Dinges E; Felderman N; TenNapel M; Bayouth JE; Flynn RT
    Med Phys; 2014 Dec; 41(12):121705. PubMed ID: 25471952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of critical structure dose and toxicity risks in patients with low grade gliomas treated with IMRT versus proton radiation therapy.
    Dennis ER; Bussiere MR; Niemierko A; Lu MW; Fullerton BC; Loeffler JS; Shih HA
    Technol Cancer Res Treat; 2013 Feb; 12(1):1-9. PubMed ID: 22775339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTCP Modeling for High-Grade Temporal Radionecroses in a Large Cohort of Patients Receiving Pencil Beam Scanning Proton Therapy for Skull Base and Head and Neck Tumors.
    Schröder C; Köthe A; De Angelis C; Basler L; Fattori G; Safai S; Leiser D; Lomax AJ; Weber DC
    Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):448-455. PubMed ID: 35124132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualization of Clinical Target Volume Delineation Based on Stepwise Spread of Nasopharyngeal Carcinoma: Outcome of More Than a Decade of Clinical Experience.
    Sanford NN; Lau J; Lam MB; Juliano AF; Adams JA; Goldberg SI; Lu HM; Lu YC; Liebsch NJ; Curtin HD; Chan AW
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):654-668. PubMed ID: 30712708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Spot Size and Beam-Shaping Devices on the Treatment Plan Quality for Pencil Beam Scanning Proton Therapy.
    Moteabbed M; Yock TI; Depauw N; Madden TM; Kooy HM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):190-198. PubMed ID: 27084640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
    Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.
    Adeberg S; Harrabi SB; Bougatf N; Bernhardt D; Rieber J; Koerber SA; Syed M; Sprave T; Mohr A; Abdollahi A; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
    Strahlenther Onkol; 2016 Nov; 192(11):770-779. PubMed ID: 27334276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining Clinical and Dosimetric Features in a PBS Proton Therapy Cohort to Develop a NTCP Model for Radiation-Induced Optic Neuropathy.
    Köthe A; van Luijk P; Safai S; Kountouri M; Lomax AJ; Weber DC; Fattori G
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):587-595. PubMed ID: 33421557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.
    Luo R; Wu VWC; He B; Gao X; Xu Z; Wang D; Yang Z; Li M; Lin Z
    BMC Cancer; 2018 May; 18(1):575. PubMed ID: 29776390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical controversies: proton radiation therapy for brain and skull base tumors.
    Combs SE; Laperriere N; Brada M
    Semin Radiat Oncol; 2013 Apr; 23(2):120-6. PubMed ID: 23473689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of 1p/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon Therapy.
    Acharya S; Robinson CG; Michalski JM; Mullen D; DeWees TA; Campian JL; Chundury A; Bottani B; Hallahan DE; Bradley JD; Huang J
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):334-343. PubMed ID: 29534896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.